Review of ESPEN-2021 Practice Guidelines for Cancer Patients: Part 1

Abstract

This study discusses the 2021 ESPEN Practical Guidelines for Nutritional Support in Oncology. The updated version of the 2021 ESPEN practice guidelines differs slightly from the 2017 version and contains flowcharts to facilitate the use of the guidelines in clinical practice, which is also relevant for domestic healthcare. ESPEN-2021 Clinical Guidelines, which offer practical solutions in all areas of oncology, are of particular interest to both oncologists and allied specialists working in oncology. The first part of the review discusses general recommendations for nutritional support for patients with cancer and the possibility of their use in our country: screening of nutritional status at the initial visit, indications for prescribing additional nutrition, benefits of one or another type of nutritional support in various situations, norms for providing macronutrients, vitamins, and minerals, and need for physical activity. This practical guide forms an algorithm of actions to ensure optimal nutrition for patients with cancer. The general principles of nutritional therapy for all patients with cancer are based on timely screening for nutritional deficiencies and adherence to appropriate nutritional support of patients, which can be achieved by modifying the diet or prescribing additional nutrition, mainly enteral nutrition.

Keywords

ESPEN-2021 / oncology / nutrition / nutritional support / enteral nutrition / parenteral nutrition / siping

References

[1] Muscaritoli M, Arends J, Bachmann P, et al. ESPEN practical guideline: Clinical Nutrition in cancer. Clin Nutr. 2021;40(5): 2898–2913. doi: 10.1016/j.clnu.2021.02.005

[2] Muscaritoli M., Arends J., Bachmann P., et al. ESPEN practical guideline: Clinical Nutrition in cancer // Clin Nutr. 2021. Vol. 40, N 5. P. 2898–2913. doi: 10.1016/j.clnu.2021.02.005

[3] Arends J, Baracos V, Bertz H, et al. ESPEN expert group recommendations for action against cancer-related malnutrition. Clin Nutr. 2017;36(5):1187–1196. doi: 10.1016/j.clnu.2016.07.015

[4] Arends J., Baracos V., Bertz H., et al. ESPEN expert group recommendations for action against cancer-related malnutrition // Clin Nutr. 2017. Vol. 36, N 5. P. 1187–1196. doi: 10.1016/j.clnu.2016.07.015

[5] Zhao XH, Yang T, Ma XD, et al. Heterogeneity of nutrition care procedures in nutrition guidelines for cancer patients. Clin Nutr. 2020;39(6):1692–1704. doi: 10.1016/j.clnu.2019.08.022

[6] Zhao X.H., Yang T., Ma X.D., et al. Heterogeneity of nutrition care procedures in nutrition guidelines for cancer patients // Clin Nutr. 2020. Vol. 39, N 6. P. 1692–1704. doi: 10.1016/j.clnu.2019.08.022

[7] Van Bokhorst-de van der Schueren MAE, Guaitoli PR, Jansma EP, de Vet HCW. Nutrition screening tools: Does one size fit all? A systematic review of screening tools for the hospital setting. Clin Nutr. 2014;33(1):39–58. doi: 10.1016/j.clnu.2013.04.008

[8] Van Bokhorst-de van der Schueren M.A.E., Guaitoli P.R., Jansma E.P., de Vet H.C.W. Nutrition screening tools: Does one size fit all? A systematic review of screening tools for the hospital setting // Clin Nutr. 2014. Vol. 33, N 1. P. 39–58. doi: 10.1016/j.clnu.2013.04.008

[9] Reber E, Gomes F, Vasiloglou MF, et al. Nutritional Risk Screening and Assessment. J Clin Med. 2019;8(7):1065. doi: 10.3390/jcm8071065

[10] Reber E., Gomes F., Vasiloglou M.F., et al. Nutritional Risk Screening and Assessment // J Clin Med. 2019. Vol. 38, N 7. P. 1065. doi: 10.3390/jcm8071065

[11] Obukhova OA, Bagrova SG, Besova NS, et al. Evaluation of the nutritional status of patients with inoperable gastric cancer at the time of initiation of anticancer treatment. Preliminary results of a prospective observational study. Difficult Patient. 2018;16(6):6–11. (In Russ).

[12] Обухова О.А., Багрова С.Г., Бесова Н.С., и др. Оценка нутритивного статуса пациентов с неоперабельным раком желудка на момент начала противоопухолевого лечения. Предварительные результаты проспективного наблюдательного исследования // Трудный пациент. 2018. Т. 16, № 6. С. 6–11.

[13] Obukhova OA, Shalenkov VA. The results of the rehabilitation program for cancer patients radically operated on for gastric cancer in the early postoperative period. 7th Saint Petersburg International Cancer Forum “Belye Nochi 2021”. Saint Petersburg; 2021. P:339. (In Russ).

[14] Обухова О.А., Шаленков В.А. Результаты проведения программы реабилитации онкологических больных, радикально оперированных по поводу рака желудка, в раннем послеоперационном периоде // VII Петербургский международный онкологический форум «Белые Ночи 2021». Санкт-Петербург, 2021. С. 339.

[15] De Haan JJ, Renken RJ, Moshage Y, et al. Self-reported taste and smell alterations and the liking of oral nutritional supplements with sensory-adapted flavors in cancer patients receiving systemic antitumor treatment. Support Care Cancer. 2021;29(10):5691–5699. doi: 10.1007/s00520-021-06049-4

[16] De Haan J.J., Renken R.J., Moshage Y., et al. Self-reported taste and smell alterations and the liking of oral nutritional supplements with sensory-adapted flavors in cancer patients receiving systemic antitumor treatment // Support Care Cancer. 2021. Vol. 29, N 10. P. 5691–5699. doi: 10.1007/s00520-021-06049-4

[17] Kashiya ShR, Kurmukov IA, Obukhova OA, et al. The use of antioxidants in the complex intensive therapy of infectious complications of drug antitumor treatment. Clinical Oncohematology. Fundamental Research and Clinical Practice. 2012;5(1):54–60. (In Russ).

[18] Кашия Ш.Р., Курмуков И.А., Обухова О.А., и др. Применение антиоксидантов в комплексной интенсивной терапии инфекционных осложнений лекарственного противоопухолевого лечения // Клиническая онкогематология. Фундаментальные исследования и клиническая практика. 2012. Т. 5, № 1. С. 54–60.

[19] Brish NA, Semiglazova TYu, Karachun AM, et al. Influence of correction of nutritive deficiency on the effectiveness of neoadjuvant chemotherapy in patients with locally advanced gastric cancer. Journal of Modern Oncology. 2021;23(3):519–524. (In Russ). doi: 10.26442/18151434.2021.3.201075

[20] Бриш Н.А., Семиглазова Т.Ю., Карачун А.М., и др. Влияние коррекции нутритивной недостаточности на эффективность неоадъювантной химиотерапии у больных местно-распространённым раком желудка // Современная онкология. 2021. Т. 23, № 3. С. 519–524. doi: 10.26442/18151434.2021.3.201075

[21] Yaroshetskiy AI, Konanykhin VD, Stepanova SO, Rezepov NA. Hypophosphatemia and refeeding syndrome in the resumption of nutrition in critical care patients (review). Alexander Saltanov Intensive Care Herald. 2019;(2):82–91. (In Russ). doi: 10.21320/1818-474X-2019-2-82-91

[22] Ярошецкий А.И., Конаныхин В.Д., Степанова С.О., Резепов Н.А. Гипофосфатемия и рефидинг-синдром при возобновлении питания у пациентов в критических состояниях (обзор литературы) // Вестник интенсивной терапии имени А.И. Салтанова. 2019. № 2. С. 82–91. doi: 10.21320/1818-474X-2019-2-82-91

[23] Besova NS, Kalinin AE, Nered SN, et al. Gastric cancer: Russian clinical guidelines. Journal of Modern Oncology. 2021;23(4):541–571. (In Russ). doi: 10.26442/18151434.2021.4.201239

[24] Бесова Н.С., Калинин А.Е., Неред С.Н., и др. Рак желудка // Современная онкология. 2021. Т. 23, № 4. С. 541–571. doi: 10.26442/18151434.2021.4.201239

[25] Laktionov KK, Artamonova EV, Borisova TN, et al. Malignant neoplasm of the bronchi and lung: Russian clinical guidelines. Journal of Modern Oncology. 2021;23(3):369–402. (In Russ). doi: 10.26442/18151434.2021.3.201048

[26] Лактионов К.К., Артамонова Е.В., Борисова Т.Н., и др. Злокачественное новообразование бронхов и лёгкого. Клинические рекомендации // Современная онкология. 2021. Т. 23, № 3. С. 369–402. doi: 10.26442/18151434.2021.3.201048

[27] Yavuzsen T, Davis MP, Walsh D, et al. Systematic review of the treatment of cancer-associated anorexia and weight loss. J Clin Oncol. 2005;23(33):8500–8511. doi: 10.1200/JCO.2005.01.8010

[28] Yavuzsen T., Davis M.P., Walsh D., et al. Systematic review of the treatment of cancer-associated anorexia and weight loss // J Clin Oncol. 2005. Vol. 23, N 33. P. 8500–8511. doi: 10.1200/JCO.2005.01.8010

RIGHTS & PERMISSIONS

Eco-Vector